167 related articles for article (PubMed ID: 9973288)
1. Hyperparathyroidism-jaw tumor syndrome: the HRPT2 locus is within a 0.7-cM region on chromosome 1q.
Hobbs MR; Pole AR; Pidwirny GN; Rosen IB; Zarbo RJ; Coon H; Heath H; Leppert M; Jackson CE
Am J Hum Genet; 1999 Feb; 64(2):518-25. PubMed ID: 9973288
[TBL] [Abstract][Full Text] [Related]
2. Hereditary hyperparathyroidism-jaw tumor syndrome: the endocrine tumor gene HRPT2 maps to chromosome 1q21-q31.
Szabó J; Heath B; Hill VM; Jackson CE; Zarbo RJ; Mallette LE; Chew SL; Besser GM; Thakker RV; Huff V
Am J Hum Genet; 1995 Apr; 56(4):944-50. PubMed ID: 7717405
[TBL] [Abstract][Full Text] [Related]
3. The hyperparathyroidism-jaw tumour syndrome in a Portuguese kindred.
Cavaco BM; Barros L; Pannett AA; Ruas L; Carvalheiro M; Ruas MM; Krausz T; Santos MA; Sobrinho LG; Leite V; Thakker RV
QJM; 2001 Apr; 94(4):213-22. PubMed ID: 11294964
[TBL] [Abstract][Full Text] [Related]
4. Tumor suppressor gene mutation in a patient with a history of hyperparathyroidism-jaw tumor syndrome and healed generalized osteitis fibrosa cystica: a case report and genetic pathophysiology review.
Parfitt J; Harris M; Wright JM; Kalamchi S
J Oral Maxillofac Surg; 2015 Jan; 73(1):194.e1-9. PubMed ID: 25511968
[TBL] [Abstract][Full Text] [Related]
5. HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome.
Carpten JD; Robbins CM; Villablanca A; Forsberg L; Presciuttini S; Bailey-Wilson J; Simonds WF; Gillanders EM; Kennedy AM; Chen JD; Agarwal SK; Sood R; Jones MP; Moses TY; Haven C; Petillo D; Leotlela PD; Harding B; Cameron D; Pannett AA; Höög A; Heath H; James-Newton LA; Robinson B; Zarbo RJ; Cavaco BM; Wassif W; Perrier ND; Rosen IB; Kristoffersson U; Turnpenny PD; Farnebo LO; Besser GM; Jackson CE; Morreau H; Trent JM; Thakker RV; Marx SJ; Teh BT; Larsson C; Hobbs MR
Nat Genet; 2002 Dec; 32(4):676-80. PubMed ID: 12434154
[TBL] [Abstract][Full Text] [Related]
6. Familial isolated hyperparathyroidism maps to the hyperparathyroidism-jaw tumor locus in 1q21-q32 in a subset of families.
Teh BT; Farnebo F; Twigg S; Höög A; Kytölä S; Korpi-Hyövälti E; Wong FK; Nordenström J; Grimelius L; Sandelin K; Robinson B; Farnebo LO; Larsson C
J Clin Endocrinol Metab; 1998 Jun; 83(6):2114-20. PubMed ID: 9626148
[TBL] [Abstract][Full Text] [Related]
7. Autosomal dominant primary hyperparathyroidism and jaw tumor syndrome associated with renal hamartomas and cystic kidney disease: linkage to 1q21-q32 and loss of the wild type allele in renal hamartomas.
Teh BT; Farnebo F; Kristoffersson U; Sundelin B; Cardinal J; Axelson R; Yap A; Epstein M; Heath H; Cameron D; Larsson C
J Clin Endocrinol Metab; 1996 Dec; 81(12):4204-11. PubMed ID: 8954016
[TBL] [Abstract][Full Text] [Related]
8. Hyperparathyroidism-jaw tumor syndrome in Roma families from Portugal is due to a founder mutation of the HRPT2 gene.
Cavaco BM; Guerra L; Bradley KJ; Carvalho D; Harding B; Oliveira A; Santos MA; Sobrinho LG; Thakker RV; Leite V
J Clin Endocrinol Metab; 2004 Apr; 89(4):1747-52. PubMed ID: 15070940
[TBL] [Abstract][Full Text] [Related]
9. A genotypic and histopathological study of a large Dutch kindred with hyperparathyroidism-jaw tumor syndrome.
Haven CJ; Wong FK; van Dam EW; van der Juijt R; van Asperen C; Jansen J; Rosenberg C; de Wit M; Roijers J; Hoppener J; Lips CJ; Larsson C; Teh BT; Morreau H
J Clin Endocrinol Metab; 2000 Apr; 85(4):1449-54. PubMed ID: 10770180
[TBL] [Abstract][Full Text] [Related]
10. Genetic studies of a family with hereditary hyperparathyroidism-jaw tumour syndrome.
Wassif WS; Farnebo F; Teh BT; Moniz CF; Li FY; Harrison JD; Peters TJ; Larsson C; Harris P
Clin Endocrinol (Oxf); 1999 Feb; 50(2):191-6. PubMed ID: 10396361
[TBL] [Abstract][Full Text] [Related]
11. Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumors.
Cetani F; Pardi E; Borsari S; Viacava P; Dipollina G; Cianferotti L; Ambrogini E; Gazzerro E; Colussi G; Berti P; Miccoli P; Pinchera A; Marcocci C
J Clin Endocrinol Metab; 2004 Nov; 89(11):5583-91. PubMed ID: 15531515
[TBL] [Abstract][Full Text] [Related]
12. Genetic analyses in patients with familial isolated hyperparathyroidism and hyperparathyroidism-jaw tumour syndrome.
Mizusawa N; Uchino S; Iwata T; Tsuyuguchi M; Suzuki Y; Mizukoshi T; Yamashita Y; Sakurai A; Suzuki S; Beniko M; Tahara H; Fujisawa M; Kamata N; Fujisawa K; Yashiro T; Nagao D; Golam HM; Sano T; Noguchi S; Yoshimoto K
Clin Endocrinol (Oxf); 2006 Jul; 65(1):9-16. PubMed ID: 16817812
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of FGFR1 expression is associated with parathyroid carcinogenesis in HPT-JT syndrome due to an HRPT2 splicing mutation.
Lee JY; Kim SY; Mo EY; Kim ES; Han JH; Maeng LS; Lee AH; Eun JW; Nam SW; Moon SD
Int J Oncol; 2014 Aug; 45(2):641-50. PubMed ID: 24889687
[TBL] [Abstract][Full Text] [Related]
14. Parafibromin mutations in hereditary hyperparathyroidism syndromes and parathyroid tumours.
Bradley KJ; Cavaco BM; Bowl MR; Harding B; Cranston T; Fratter C; Besser GM; Conceição Pereira M; Davie MW; Dudley N; Leite V; Sadler GP; Seller A; Thakker RV
Clin Endocrinol (Oxf); 2006 Mar; 64(3):299-306. PubMed ID: 16487440
[TBL] [Abstract][Full Text] [Related]
15. Frequent large germline HRPT2 deletions in a French National cohort of patients with primary hyperparathyroidism.
Bricaire L; Odou MF; Cardot-Bauters C; Delemer B; North MO; Salenave S; Vezzosi D; Kuhn JM; Murat A; Caron P; Sadoul JL; Silve C; Chanson P; Barlier A; Clauser E; Porchet N; Groussin L;
J Clin Endocrinol Metab; 2013 Feb; 98(2):E403-8. PubMed ID: 23293331
[TBL] [Abstract][Full Text] [Related]
16. HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours.
Howell VM; Haven CJ; Kahnoski K; Khoo SK; Petillo D; Chen J; Fleuren GJ; Robinson BG; Delbridge LW; Philips J; Nelson AE; Krause U; Hammje K; Dralle H; Hoang-Vu C; Gimm O; Marsh DJ; Morreau H; Teh BT
J Med Genet; 2003 Sep; 40(9):657-63. PubMed ID: 12960210
[TBL] [Abstract][Full Text] [Related]
17. A Novel IVS2-1G>A mutation causes aberrant splicing of the HRPT2 gene in a family with hyperparathyroidism-jaw tumor syndrome.
Moon SD; Park JH; Kim EM; Kim JH; Han JH; Yoo SJ; Yoon KH; Kang MI; Lee KW; Son HY; Kang SK; Oh SJ; Kim KM; Yoon SJ; Park JG; Kim IJ; Kang HC; Hong SW; Kim KR; Cha BY
J Clin Endocrinol Metab; 2005 Feb; 90(2):878-83. PubMed ID: 15613436
[TBL] [Abstract][Full Text] [Related]
18. Mapping the gene causing hereditary primary hyperparathyroidism in a Portuguese kindred to chromosome 1q22-q31.
Williamson C; Cavaco BM; Jauch A; Dixon PH; Forbes S; Harding B; Holtgreve-Grez H; Schoell B; Pereira MC; Font AP; Loureiro MM; Sobrinho LG; Santos MA; Thakker RV
J Bone Miner Res; 1999 Feb; 14(2):230-9. PubMed ID: 9933477
[TBL] [Abstract][Full Text] [Related]
19. Dental findings in a family with hyperparathyroidism-jaw tumor syndrome and a novel HRPT2 gene mutation.
Aldred MJ; Talacko AA; Savarirayan R; Murdolo V; Mills AE; Radden BG; Alimov A; Villablanca A; Larsson C
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Feb; 101(2):212-8. PubMed ID: 16448924
[TBL] [Abstract][Full Text] [Related]
20. Hyperparathyroidism-jaw tumor syndrome: Results of operative management.
Mehta A; Patel D; Rosenberg A; Boufraqech M; Ellis RJ; Nilubol N; Quezado MM; Marx SJ; Simonds WF; Kebebew E
Surgery; 2014 Dec; 156(6):1315-24; discussion 1324-5. PubMed ID: 25444225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
